Neuland Laboratories Adjusts Outlook Amid Mixed Technical Indicators and Sales Decline
Neuland Laboratories has recently experienced a score adjustment reflecting a shift in technical trends. While technical indicators show mixed signals, the company has faced challenges with a notable decline in net sales. Despite this, it maintains a strong debt servicing capability and significant institutional backing.
Neuland Laboratories, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment. This revision in its score reflects a shift in technical trends, moving from a mildly bullish stance to a bullish outlook. The technical indicators present a mixed picture; while the Moving Averages and Bollinger Bands indicate bullish signals on both weekly and monthly bases, the MACD shows a bullish trend weekly but mildly bearish monthly. The KST also aligns with this trend, being bullish weekly and mildly bearish monthly.
Despite the positive technical indicators, Neuland Laboratories has faced challenges in its financial performance. The company reported a significant decline in net sales of -10.84% for the quarter ending June 2025, contributing to a series of negative results over the last four quarters. However, it maintains a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 0.57 times, and has high institutional holdings at 33.66%, suggesting a robust analytical backing from larger investors.
Overall, while Neuland Laboratories has shown consistent returns over the past three years, its long-term growth has been limited, with net sales and operating profit growing at annual rates of 11.06% and 14.31%, respectively, over the last five years.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
